Axa
HAE icon

Axa’s Haemonetics HAE Stock Holding History

Axa’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-51,400
Closed -$4.01M – 1086
2024
Q4 		$4.01M Sell
51,400
-6,730
-12% -$541K 0.01% 596
2024
Q3 		$4.67M Buy
58,130
+4,505
+8% +$364K 0.01% 568
2024
Q2 		$4.44M Sell
53,625
-50
-0.1% -$4.4K 0.01% 558
2024
Q1 		$4.58M Sell
53,675
-25
-0% -$1.96K 0.01% 573
2023
Q4 		$4.59M Buy
53,700
+1,700
+3% +$147K 0.01% 569
2023
Q3 		$4.66M Sell
52,000
-800
-2% -$71.4K 0.02% 545
2023
Q2 		$4.5M Buy
52,800
+7,500
+17% +$634K 0.01% 577
2023
Q1 		$3.75M Buy
+45,300
New +$3.67M 0.01% 635
2021
Q4 		– Sell
-4,500
Closed -$318K – 1222
2021
Q3 		$318K Buy
+4,500
New +$284K ﹤0.01% 1138
2021
Q2 		– Sell
-9,500
Closed -$1.05M – 1268
2021
Q1 		$1.05M Hold
9,500
– – ﹤0.01% 970
2020
Q4 		$1.13M Hold
9,500
– – ﹤0.01% 954
2020
Q3 		$829K Sell
9,500
-1,300
-12% -$114K ﹤0.01% 969
2020
Q2 		$967K Hold
10,800
– – ﹤0.01% 960
2020
Q1 		$1.08M Buy
+10,800
New +$1.17M 0.01% 843
2017
Q4 		– Sell
-21,200
Closed -$951K – 1367
2017
Q3 		$951K Buy
+21,200
New +$881K ﹤0.01% 968
2017
Q2 		– Sell
-7,200
Closed -$292K – 1263
2017
Q1 		$292K Buy
+7,200
New +$281K ﹤0.01% 1165
2016
Q3 		– Sell
-21,800
Closed -$632K – 1254
2016
Q2 		$632K Buy
+21,800
New +$659K ﹤0.01% 959

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Axa's HAE Position: Q1 2025 in Review

Axa sold out of Haemonetics (HAE) in Q1 2025, closing a stake of 51,400 shares — an estimated $4.01M sold.

Axa first reported a position in HAE in Q2 2016 and held it in 17 quarters. The position peaked at $4.67M in Q3 2024. 314 funds tracked by Wall St. Rank hold HAE as of Q1 2025.

  • Axa reported no remaining Haemonetics position as of Q1 2025 after selling out during the quarter.
  • Axa sold 51,400 Haemonetics shares in Q1 2025, an estimated $4.01M.
  • Axa first reported a position in Haemonetics in Q2 2016 and held it in 17 quarters.
  • Axa's Haemonetics position peaked at $4.67M in Q3 2024.
  • 314 funds tracked by Wall St. Rank held Haemonetics as of Q1 2025.

Based on Axa's 13F filing for Q1 2025, filed 15 May 2025.